baber/WOPTO huggingface dataset:
Patent JP-3001594-B2 (JP)
IPC: G02B1/04
Filed: 1989-11-27
Granted: 2000-01-24
Abstract: Shaped hydrogel articles such as soft contact lenses are prepared by (1) molding or casting a polymerization mixture comprising: (a) a monomer mixture comprising a major proportion of a hydrophilic (meth)acrylate ester such as 2-hydroxyethyl methacrylate, and a cross-linking monomer; and (b) a water-displaceable diluent, wherein said diluent has a viscosity of at least 100 MPa Sec at 30 DEG C, and wherein said diluent consists essentially of a boric acid ester of certain dihydric alcohols, said dihydric alcohols having Hansen polar ( delta p) and Hansen hydrogen bonding ( delta h) cohesion parameters falling within the area of a circle defined as having a center at delta h = 20.5,  delta p = 13, and a radius of 8.5, to produce a shaped gel of a copolymer of said monomers and said diluent, and (2) thereafter replacing said diluent with water.
Patent JP-3521946-B2 (JP)
IPC: F17C13/12
Filed: 1993-12-27
Granted: 2004-04-26
Abstract: In an evaporated gas supply method in which the liquid seal obtained by expansion of the evaporated gas can be effectively avoided, which comprises the step of cooling down the evaporated gas (2) in a cylinder (1), whereby the enthalpy of the evaporated gas (2) filled in the said cylinder (1) is increased over the enthalpy of the secondary pressure on the saturated vapor line in a pressure-enthalpy diagram of the same evaporated gas (2), and the step of adiabatically expanding the evaporated gas (2) filled in the cylinder (1) so that its pressure is reduced, and supplying the evaporated gas having the reduced pressure to said consuming installation (3). <IMAGE>
Patent JP-2632634-B2 (JP)
IPC: A61K8/19
Filed: 1992-12-03
Granted: 1997-07-23
Abstract: A rare earth sesquisulphide of formula M2S3 has an interstitial structure (in which M is an element from the lanthanide gp. or yttrium, and contg. an alkaline earth element as a dopant). At least part of the latter is included in the crystal lattice of the sulphide, and the material is in the form of a powder of average particle size 0.2-5 microns. Also claimed are their prepn..
Patent JP-3336617-B2 (JP)
IPC: H04B1/66
Filed: 1994-05-31
Granted: 2002-10-21
Abstract: This method comprises the steps of converting the inputted acoustic signals into the frequency component; separating the output of conversion means to the tone component and the other component (noise component); coding the tone component; coding the noise component; and generating the code string from the output of the coding step. <IMAGE>
Patent JP-3620600-B2 (JP)
IPC: A23L2/395
Filed: 1995-05-23
Granted: 2005-02-16
Abstract: This invention relates to a composition, preferably in the form of a beverage, whereby cellular hydration and drinkability are enhanced by the combination of green tea solids with selected levels and types of electrolytes and carbohydrates. The compositions comprise (a) from about 0.01% to about 0.35% flavanols; (b) from about 0.01% to about 0.3% sodium ions; (c) from about 0.005% to about 0.08% potassium ions; (d) from about 0.1% to about 20% of a carbohydrate which provides; (i) from about 0.05% to about 10.0% fructose; (ii) from about 0.05% to about 10.0% glucose; and (e) water.
Patent JP-4307556-B2 (JP)
IPC: B22D11/06
Filed: 1997-06-03
Granted: 2009-08-05
Abstract: PCT No. PCT/DE97/01150 Sec. 371 Date Feb. 17, 1999 Sec. 102(e) Date Feb. 17, 1999 PCT Filed Jun. 3, 1997 PCT Pub. No. WO97/47411 PCT Pub. Date Dec. 18, 1997A supporting arrangement for the transport belt in thin strip casting plants. The liquid steel is cast onto the circulating transport belt. On its underside, the transport belt has devices for generating a negative pressure and for supporting the belt as well as for cooling. In the past, rollers were used for supporting the belt. Between the supporting points of the belt on the rollers, upward curvatures of the belt may occur. This is avoided by the use of supports of which the spacings measured transversely to the transporting direction are greater than the lengths of the supports in this direction.
Patent JP-2781272-B2 (JP)
IPC: C07C29/136
Filed: 1990-01-16
Granted: 1998-07-30
Abstract: PCT No. PCT/GB90/00063 Sec. 371 Date Aug. 12, 1991 Sec. 102(e) Date Aug. 12, 1991 PCT Filed Jan. 16, 1990 PCT Pub. No. WO90/08121 PCT Pub. Date Jul. 26, 1990.An improved process for the production of fatty alcohols is provided. The fatty alcohols are produced by hydrogenation of lower alkyl esters, especially methyl esters, of fatty acids derived from natural triglycerides, under conditions which minimize formation of by-product alkanes and ethers. The hydrogenation is followed by refining of any resulting ester-containing hydrogenation product to produce a substantially ester free fatty alcohol.
Patent JP-2968333-B2 (JP)
IPC: F16B25/10
Filed: 1990-03-23
Granted: 1999-10-25
Abstract: Hole forming and selftapping screw of up to approximately 6 mm thread diameter for tapping into sheet metal of a thickness of up to approximately 1 mm comprising a head including a formation for receiving a tool, a thread shank and a cylinder member following thereon having a diameter less than the thread-pitch diameter of the thread shank, merging into a tapered hole forming member. The thread shank merges with the cylinder member via a taper extending over approximately four threads, a distance corresponding approximately to the four-fold sheet metal thickness. The hole forming member terminates in a convexly curved friction surface corresponding to a radius (R) of approximately 0.5 mm. The entire screw is formed in one piece of tempered steel having a tensile strength of up to approximately 1400 N/mm2, mechanically hardened steel respectively.
Patent JP-3062248-B2 (JP)
IPC: C07D335/06
Filed: 1992-02-11
Granted: 2000-07-10
Abstract: Novel compounds of the formula   <IMAGE>   where X is S, O; R1-R5 are hydrogen or lower alkyl; R6 is lower alkyl, lower alkenyl, lower cycloalkyl having 1 to 6 carbons, or halogen; A is lower branched chain alkyl having 2 to 6 carbons, cycloalkyl having 3 to 6 carbons, alkenyl having 2 to 6 carbons and 1 or 2 double bonds, alkynyl having 2 to 6 carbons and 1 or 2 triple bonds, (CH2)n where n is 0-5; and B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, COONR9R10, -CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, -COR'', CR''(OR12)2, or CR''OR13O, where R'' is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R11 is lower alkyl, phenyl or lower alkylphenyl, R12 is lower alkyl, R13 is divalent alkyl radical of 2-5 carbons, have retinoic acid like activity.
Patent JP-3364685-B2 (JP)
IPC: B23K26/38
Filed: 1993-02-05
Granted: 2003-01-08
Abstract: Nozzles for an ink jet printer are formed by laser ablation in a nozzle plate which has previously been bonded to the body of the printer. The laser beam is caused to converge at a point in front of the nozzle plate so that a nozzle is formed which tapers toward the outlet. First and second beam masks are established in front of a focussing lens with the masks being respectively conjugate in the lens with the nozzle inlet and outlet, which are of different shape. The nozzle has a central land which controls the ink meniscus and avoids the ejected drop receiving a sideways kick from the nozzle wall.
Patent JP-2689023-B2 (JP)
IPC: A61K38/00
Filed: 1991-08-15
Granted: 1997-12-10
Abstract: A non-immunogenic mixture of hemoglobin based modified monomers and oligomers produced by the polymerization of a hemoglobin based solution in the presence of a three membered heterocyclic ring, i.e. polyether oxirane. The modified hemoglobin composition has a P50 of at least equivalent to the P50 of human red blood cell hemoglobin.
Patent JP-3294613-B2 (JP)
IPC: B41J3/28
Filed: 1993-03-03
Granted: 2002-06-24
Abstract: PCT No. PCT/GB93/00440 Sec. 371 Date Dec. 27, 1994 Sec. 102(e) Date Dec. 27, 1994 PCT Filed Mar. 3, 1993 PCT Pub. No. WO93/17872 PCT Pub. Date Aug. 16, 1993.A hand-held marking device comprises an electrically actuated writing head for making marks on a writing surface and a sensor for detecting when the writing head is moving in any direction in a plane parallel to the surface. The device includes a mechanism for causing the head to be actuated when the sensor detects relative movement of the writing head and the surface. The writing head can be arranged to be able to make a plurality of different types or sizes of marks on a writing surface, in which case a mechanism is provided for selecting which of the different mark types or sizes is to be made.
Patent JP-2546544-B2 (JP)
IPC: C07K19/00
Filed: 1990-10-26
Granted: 1996-10-23
Abstract: This invention discloses immunopotentiating agents which stimulate an immune response. These agents are categorised into single agents that act directly, adjuvants added concurrently with the agents, or heteroconjugates. Heteroconjugate agents elicit or enhance a cellular or humoral immune response which may be specific for an epitope contained within an amino acid sequence. Enhanced hematopoieses by bone marrow stem cell recruitment was also a result of administering soime of these agents. Examples of immunopotentiating agents include monoclonal antibodies and proteins derived from microorganisms (e.g., enterotoxins) which activate T cells. One method of treatment disclosed uses only the immunopotentiating agent to stimulate the immune system. Another uses adjuvants in combination with the agent. A third method employs heteroconjugates. Heteroconjugates comprise: (a) an immunopotentiating protein which is characterised as having an ability to stimulate T cells; and (b) a second protein having an amino acid sequence which includes an epitope against which a cellular or humoral response is desired. This invention also relates to a method of preparing the heteroconjugate, and to a method of stimulating the immune system in vivo in a novel way. One route of stimulation is to activate T cells, in some instances, specific subsets of T cells, by administering heteroconjugates containing an immunopotentiating protein and a second protein, to mammals. For this method of treatment, the second protein in the heteroconjugate is derived from abnormal or diseased tissue, or from an infectious agent, alternatively, the second protein is produced synthetically by standard methods of molecular biology. Sources of the second protein include tumors, viruses, bacteria, fungi, protozoal or metozoal parasites. Monoclonal antibodies or T cells prepared from mammals whose immune systems have responded to administration of the heteroconjugate may be produced and administered to induce passive immunity. A method of preparing a hybridoma which secretes said monoclonal antibodies and use of these monoclonal antibodies and T cells, are also disclosed. This invention is also directed to a vaccine comprising the heteroconjugate.
Patent JP-H0778316-B2 (JP)
IPC: C11D7/22
Filed: 1991-09-27
Abstract: PCT No. PCT/CA91/00350 Sec. 371 Date Jun. 25, 1993 Sec. 102(e) Date Jun. 25, 1993 PCT Filed Sep. 27, 1991 PCT Pub. No. WO92/06241 PCT Pub. Date Apr. 16, 1992.Brown stock washing of wood pulp is improved by adding a water-soluble cationic polymer to the wash water. The cationic polymer reacts with lignin solution present in the larger channels in the pulp mat to give a precipitate which lowers the flow rate of wash water through the larger channels. A more efficient wash water usage is obtained.
Patent JP-4131569-B2 (JP)
IPC: A61P21/04
Filed: 1997-12-01
Granted: 2008-08-13
Abstract: This invention relates to gene delivery and expression, including gene therapy, by using vectors which encode stable mRNA and methods of using such vectors. In particular, this invention relates to vectors which establish controlled expression of recombinant IGF-I genes within tissues at certain levels. The vector includes a 5' flanking region which includes necessary sequences for expression of a nucleic acid cassette, a 3' flanking region including a 3' UTR and/or 3' NCR, and a linker which connects the 5' flanking region to a nucleic acid sequence. The linker has a position for inserting a nucleic acid cassette. The linker does not contain the coding sequence of a gene that the linker is naturally associated with. The 3' flanking region is 3' to the position for inserting the nucleic acid cassette. The expression vectors of the present invention can also be regulated by a regulatory system and/or constructed with a coating.
Patent JP-3288385-B2 (JP)
IPC: H01L23/525
Filed: 1997-02-06
Granted: 2002-06-04
Abstract: The invention relates to a separable connecting bridge (fuse) with an electrically conductive, longitudinally continuous conductive track (1) of a given width transversely to its length of a second type of conductivity opposite to the first, said track being formed in a substrate (2, 2a) of a first type of conductivity, where the semiconductor material of the first type of conductivity has a concentration in relation to the material of the conductive track such that, at a predetermined activation temperature which is higher than the operating temperature of the connecting bridge (12, 13), an interruption takes place over the entire width (m) of the conductive track (1) through the diffusion of the semiconductor material of the first type of conductivity and/or the material of the conductive track (1) of the second type of conductivity.  00000
Patent JP-3470198-B2 (JP)
IPC: A61K9/00
Filed: 1996-04-30
Granted: 2003-11-25
Abstract: ÄObjectÜ To provide a composition for oral administration which is excellent in masking a taste of an unpleasant tasting drug and in bioavailability. ÄConstitutionÜ A composition for oral administration comprising an unpleasantly tasting drug, a high polymer soluble in the stomach and a monoglyceride in the  beta -crystal form.
Patent JP-4203614-B2 (JP)
IPC: A61M5/24
Filed: 1997-10-04
Granted: 2009-01-07
Abstract: An original injection unit has a casing (112) and a section forcing the injected fluid from a vessel (118). It is moved by the operating section (170) which travels longitudinally in the device between end positions. There is a position-dependent connection (166) between the two, which is deactivated in the far end position of the operating section. In a region following the far end position of the operational section, it is activated.
Patent JP-4045364-B2 (JP)
IPC: C07C215/00
Filed: 1998-04-03
Granted: 2008-02-13
Abstract: The present invention relates to a compound of the general formula <CHEM> wherein m is 0 to 9, and R<1a>, R<2a>, R<3a> and R<4a> are the same or different and each is a hydrogen or an acyl, with the proviso that m is not 4; a pharmaceutically acceptable acid addition salt thereof or a hydrate thereof; a pharmaceutical comprising this compound; and a pharmaceutical composition comprising this compound and a pharmaceutically acceptable carrier. The compound of the present invention shows superior immunosuppressive action with less toxicity and higher safety, and is useful as a drug for preventing or suppression of rejection of organs or bone marrow transplantation, or as a drug for prevention or treatment of various autoimmune diseases or allergic diseases.
Patent ES-2221515-B2 (ES)
Title: Unidad de estampacion y sistema de movimiento relacionado.
Inventor: BARTESAGHI ANGELO
IPC: B23D35/00
Filed: 2002-03-20
Granted: 2005-10-16
Abstract: Unidad de estampación y sistema de movimiento relacionado. Unidad de estampación que comprende al menos un módulo de estampación (1,1'',1 `'') que comprende dos rodillos de estampación (5,6) que giran en sentido contrario para la estampación de material de hoja, particularmente para la producción de pañuelos de papel y similares, donde el módulo de estampación está dispuesto en línea con una plataforma de plegado (3) para plegar el material de hoja que sale del módulo de estampación y está montado en una plataforma de soporte (2) móvil para ser capaz de moverse desde una posición de trabajo hasta una posición de descanso.
Patent ES-2209650-B2 (ES)
Title: Mamiferos no humanos mutantes deficientes en receptores sigma y sus aplicaciones.
Inventor: ZAMANILLO CASTANEDO DANIEL
IPC: C12N15/90
Filed: 2002-12-09
Granted: 2006-11-01
Abstract: Mamíferos no humanos mutantes deficientes en receptores sigma y sus aplicaciones. El genoma del mamífero no humano mutante, deficiente en un receptor Sigma endógeno, contiene una mutación que comprende una disrupción en un gen de un receptor Sigma endógeno, en donde dicha disrupción génica da lugar a un mutante que carece de niveles detectables de receptor Sigma endógeno. El mutante puede ser utilizado como animal control para ensayos in vivo así como fuente de células que pueden ser utilizadas en ensayos in vitro. Los mutantes deficientes en el receptor Sigma-1 pueden utilizarse como modelos para estudiar in vivo desórdenes del sistema nervioso central, alteraciones de la memoria, condiciones de estrés y adicción a drogas, procesos de analgesia y neuroprotección. Los mutantes deficientes en el receptor Sigma- 2 pueden utilizarse para estudiar herramientas, diagnósticas o terapéuticas, para combatir el cáncer y/o procesos degenerativos y/o para el diseño de compuestos capaces de prevenir, reducir o aliviar la patología secundaria asociada a la administración de agentes neurolépticos.
Patent ES-2272113-B2 (ES)
Title: Mejoras introducidas en la patente de invencion solicitada con el numero 9901477 relativa a un bogie de rodadura de ancho variable autopropulsado.
Inventor: MOLINER LORIENTE NICOLAS
IPC: B61F7/00
Filed: 2003-12-18
Granted: 2008-02-16
Abstract: Mejoras introducidas en la Patente de Invención solicitada con el número 9901477 relativa a un bogie de rodadura de ancho variable autopropulsado que consiste en un bogie provisto de roldanas de sustentación que se encuentran montadas en las cajas soporte (16), sino sobre soportes (18) fijados al bastidor (19) del bogie, contando con un cerrojo (14) de seguridad accionado por los carriles (17) de apoyo lateral situados distanciados de las cajas (16) soporte.
Patent ES-2253963-B2 (ES)
Title: Dispositivo de cierre para recipientes.
Inventor: AMARANTI ROSSI ROBERTO
IPC: G09F19/14
Filed: 2002-04-16
Granted: 2007-07-16
Abstract: Dispositivo de cierre para recipientes, que comprende un plano principal (4) desde cuyo perímetro se proyecta una pared lateral (5), definiendo dicho plano principal (4) una primera superficie interior (6) del dispositivo (1), comprendiendo dicho dispositivo (1) un elemento decorativo interactivo (3) asociado con la primera superficie interior (6) del dispositivo (1).
Patent ES-2245872-B2 (ES)
Title: Composicion de gasoleo o combustible destilado medio estabilizado.
Inventor: DELGADO DIESTRE JESUS
IPC: C10L1/22
Filed: 2004-03-22
Granted: 2006-12-01
Abstract: Una composición de gasóleo o combustible destilado medio estabilizados mediante la adición de una combinación de un desactivador de metales y al menos otro compuesto seleccionado de dispersantes, antioxidantes y estabilizantes frente a la luz, así como al uso de dicha composición como gasóleo de calefacción un procedimiento de obtención de dicha composición.
Patent AU-2001234770-B2 (AU)
Title: Subsea pig launcher
Inventor: CLEGG WILLIAM
IPC: F16L55/46
Filed: 2001-02-02
Granted: 2005-10-13
Abstract: A multiple pig subsea pig launcher is disclosed. The pig launcher can be assembled on a production pipeline subsea with the aid of an ROV. In the preferred embodiment, the pigs are connected to each other and spaced apart by a spine. The pig launcher is configured to capture the next pig to be launched in such a manner that the spine behind it is in alignment with a shearing valve; for example, coiled tubing or wireline. Sequential valve operation shears the spine and applies pressure behind the pig to launch it from the launcher past the pig detector and onto a platform for recapture.
Patent AU-2001245675-B2 (AU)
Title: G-protein coupled receptors
Inventor: CUTLER GENE
IPC: G01N33/53
Filed: 2001-03-13
Granted: 2005-11-03
Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
Patent AU-2001248836-B2 (AU)
Title: Method And Apparatus For Producing Fine Particles, And Fine Particles
Inventor: FURUYA MASAHIRO
IPC: B22F9/08
Filed: 2001-04-23
Granted: 2005-05-12
Abstract: A method and apparatus are invented for producing fine particles, which can readily realize the formation of fine particles of sub- mu m order to 100 micron order as well as fine particles of several micrometer which cannot be realized by a conventional method and apparatus available for producing fine particles, and a large quantity of fine particles having the desired particle diameter can be obtained with a high yield. A molten material (1), which is a molten raw material to be fragmented into fine particles, is supplied into a liquid coolant (4), boiling due to spontaneous-bubble nucleation is generated, and the molten material (1) is cooled and solidified while forming fine particles thereof by utilizing a pressure wave generated by this boiling. This production method is realized by apparatus comprising: material supplying means (3); a cooling section (2) which brings in the coolant (4) whose quantity is small and sufficient for cooling and solidifying the supplied molten material (1), and cools and solidifies the molten material (1) while forming fine particles thereof by utilizing a pressure wave generated by boiling due to spontaneous-bubble nucleation; and recovery means (5) for recovering fine particles from the coolant (4). <IMAGE>
Patent AU-2001260674-B2 (AU)
Title: Tnf-alpha production inhibitors
Inventor: BAN MASAKAZU
IPC: A61P37/06
Filed: 2001-05-31
Granted: 2006-03-30
Abstract: A purpose of the present invention is to provide TNF-± production inhibitors being useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. Novel compounds having the structure represented by the general formula [1] or salts thereof according to the present invention have excellent TNF-± production inhibitory activities,   
wherein "A" is -(NR 4 )-, or -O-, "B" is alkylene or alkenylene, R 1 , R 2  and R 4  are hydrogen, alkyl, alkenyl, adamantyl or the like, R 3  is a pyridine ring, and "X" is oxygen or sulfer respectively.
Patent AU-2001267705-B2 (AU)
Title: Neuroprotective 7-beta-hydroxysteroids
Inventor: SUNDSTROM LARS ERIC
IPC: A61K31/56
Filed: 2001-06-29
Granted: 2005-08-18
Abstract: 3-Hydroxy-7β-hydroxy steroids and 3-oxo-7β-hydroxy steroids and pharmaceutically acceptable estors thereof are useful for protection against neuronal damage.
Patent AU-2002223098-B2 (AU)
Title: Suspension arrangement
Inventor: ROYCROFT TERRENCE JAMES
IPC: B60F3/00
Filed: 2001-11-30
Granted: 2006-12-07
Abstract: Vehicle suspension having a control arm pivotally mounted to vehicle body. Wheel support is pivotally mounted to the control arm. A hydraulic strut is pivotally mounted to body at trunnion mount. The wheel may be protracted to be placed vertically on the road surface or retracted at an angle, for example to allow good marine performance in an amphibious vehicle. Strut may be extended or retracted by hydraulic fluid pumped through ports and may also be used for wheel springing and damping. As trunnion mount is part way up the strut, the strut can pivot out of the way of the retracing wheel. A second control arm may also be fitted; this may be part of a double wishbone wheel suspension.